Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Sodium 2-hydroxylinoleate

EU orphan designation number: EU/3/15/1485   
Active ingredient: Sodium 2-hydroxylinoleate
Indication: Treatment of neuroblastoma
Sponsor: Ability Pharmaceuticals SL
Edifici Eureka, Campus de la UAB, 08193 Bellaterra, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/04/2015 Orphan designation EMA/OD/326/14 (2015)2949 of 24/04/2015